Phenotypic drug discovery: a case for thymosin alpha-1.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Phenotypic drug discovery: a case for thymosin alpha-1.
- Published In:
- Frontiers in medicine, 11, 1388959 (2024)
- Authors:
- Garaci, Enrico(17), Paci, Maurizio, Matteucci, Claudia(5), Costantini, Claudio, Puccetti, Paolo, Romani, Luigina
- Database ID:
- RPEP-08244
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-08244APA
Garaci, Enrico; Paci, Maurizio; Matteucci, Claudia; Costantini, Claudio; Puccetti, Paolo; Romani, Luigina. (2024). Phenotypic drug discovery: a case for thymosin alpha-1.. Frontiers in medicine, 11, 1388959. https://doi.org/10.3389/fmed.2024.1388959
MLA
Garaci, Enrico, et al. "Phenotypic drug discovery: a case for thymosin alpha-1.." Frontiers in medicine, 2024. https://doi.org/10.3389/fmed.2024.1388959
RethinkPeptides
RethinkPeptides Research Database. "Phenotypic drug discovery: a case for thymosin alpha-1." RPEP-08244. Retrieved from https://rethinkpeptides.com/research/garaci-2024-phenotypic-drug-discovery-a
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.